NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 343 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,296,575 | -9.1% | 51,900 | 0.0% | 0.12% | -8.1% |
| Q2 2023 | $2,525,454 | -12.4% | 51,900 | 0.0% | 0.14% | +10.7% |
| Q1 2023 | $2,881,488 | +38.2% | 51,900 | 0.0% | 0.12% | +38.6% |
| Q4 2022 | $2,084,823 | -91.2% | 51,900 | -91.1% | 0.09% | -87.9% |
| Q1 2022 | $23,784,000 | -60.0% | 584,660 | -8.1% | 0.73% | -36.8% |
| Q4 2021 | $59,411,000 | -28.7% | 636,160 | -14.9% | 1.15% | -18.0% |
| Q3 2021 | $83,270,000 | +107.4% | 747,220 | +111.3% | 1.40% | +133.4% |
| Q2 2021 | $40,156,000 | – | 353,700 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |